GC
PTGX icon

Guggenheim Capital’s Protagonist Therapeutics PTGX Stock Holding History

Guggenheim Capital’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Sell
15,280
-15,816
-51% -$1.4M 0.01% 781
2025
Q4 		$2.72M Buy
31,096
+12,513
+67% +$1.02M 0.02% 584
2025
Q3 		$1.23M Sell
18,583
-625
-3% -$35.5K 0.01% 849
2025
Q2 		$1.06M Buy
19,208
+303
+2% +$14.5K 0.01% 869
2025
Q1 		$914K Sell
18,905
-173
-0.9% -$7.25K 0.01% 914
2024
Q4 		$736K Buy
19,078
+11,180
+142% +$487K 0.01% 1070
2024
Q3 		$355K Buy
+7,898
New +$319K ﹤0.01% 1541

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return